These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 28673657)

  • 1. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors.
    Dai Y; Covarrubias D; Uppot R; Arellano RS
    J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
    McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
    J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors.
    Gervais DA; McGovern FJ; Arellano RS; McDougal WS; Mueller PR
    Radiology; 2003 Feb; 226(2):417-24. PubMed ID: 12563135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: specific technical aspects and clinical results.
    Sommer CM; Lemm G; Hohenstein E; Bellemann N; Stampfl U; Goezen AS; Rassweiler J; Kauczor HU; Radeleff BA; Pereira PL
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):731-7. PubMed ID: 22926302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes.
    Ahrar K; Matin S; Wood CG; Wallace MJ; Gupta S; Madoff DC; Rao S; Tannir NM; Jonasch E; Pisters LL; Rozner MA; Kennamer DL; Hicks ME
    J Vasc Interv Radiol; 2005 May; 16(5):679-88. PubMed ID: 15872323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous radiofrequency ablation of sporadic Bosniak III or IV lesions: treatment techniques and short-term outcomes.
    Park JJ; Park BK; Park SY; Kim CK
    J Vasc Interv Radiol; 2015 Jan; 26(1):46-54. PubMed ID: 25446421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
    Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE
    AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
    Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
    Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image-guided thermal ablation of central renal tumors with retrograde cold pyeloperfusion technique: a monocentric experience.
    Mauri G; Rossi D; Bonomo G; Camisassi N; Della Vigna P; Maiettini D; Varano GM; Monfardini L; Mascagni L; Orsi F
    Int J Hyperthermia; 2020; 37(1):660-667. PubMed ID: 32552069
    [No Abstract]   [Full Text] [Related]  

  • 10. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water.
    Cantwell CP; Wah TM; Gervais DA; Eisner BH; Arellano R; Uppot RN; Samir AE; Irving HC; McGovern F; Mueller PR
    J Vasc Interv Radiol; 2008 Jul; 19(7):1034-40. PubMed ID: 18589317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Safety and Efficacy of Percutaneous Microwave Ablation of Central Versus Peripheral Renal Cell Carcinoma.
    An TJ; Arellano RS
    Cardiovasc Intervent Radiol; 2021 Feb; 44(2):281-288. PubMed ID: 33078234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
    Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
    Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal masses.
    Andersson M; Hashimi F; Lyrdal D; Lundstam S; Hellström M
    Acta Radiol; 2015 Dec; 56(12):1519-26. PubMed ID: 25414370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chyluria after radiofrequency ablation of renal tumors.
    Kaur H; Matin SF; Javadi S; Johnson VE; Choi H; Sandler C; Ahrar K
    J Vasc Interv Radiol; 2011 Jul; 22(7):924-7. PubMed ID: 21507680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous CT-guided radiofrequency ablation of renal cell carcinoma: efficacy of organ displacement by injection of 5% dextrose in water into the retroperitoneum.
    Arellano RS; Garcia RG; Gervais DA; Mueller PR
    AJR Am J Roentgenol; 2009 Dec; 193(6):1686-90. PubMed ID: 19933665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency Ablation of T1a Renal Cell Carcinomas within Renal Transplant Allografts: Oncologic Outcomes and Graft Viability.
    Cool DW; Kachura JR
    J Vasc Interv Radiol; 2017 Dec; 28(12):1658-1663. PubMed ID: 28916346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors.
    Javadi S; Ahrar JU; Ninan E; Gupta S; Matin SF; Ahrar K
    J Vasc Interv Radiol; 2010 May; 21(5):690-5. PubMed ID: 20227295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms.
    Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Shimada J; Nishimura T
    Diagn Interv Radiol; 2007 Dec; 13(4):199-203. PubMed ID: 18092293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal tumors: technical success and early clinical experience with radiofrequency ablation of 18 tumors.
    Sabharwal R; Vladica P
    Cardiovasc Intervent Radiol; 2006; 29(2):202-9. PubMed ID: 16447001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.